Comments

NeuroSense Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does NeuroSense Therapeutics (NRSNW) operate in?

NeuroSense Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

NRSNWNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$0.2600

At close: Apr 17, 12:47 PM EDT

$0.2500

-0.01-3.85%

Pre-Market: Feb 21, 9:18 AM EDT

NeuroSense Therapeutics (NRSNW) Forecast

News Earnings NeuroSense Therapeutics (NRSNW) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

NeuroSense Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:NRSNW | Benzinga

Explore NeuroSense Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for NRSNW.

Open	-
Close	-
Volume / Avg.	0 / 15.83K
Day Range	- - -
52 Wk Range	0.10 - 1.06
Market Cap	-
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	-
Days to Cover	1

Recent News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	-
Close	-
Volume / Avg.	0 / 15.83K
Day Range	- - -
52 Wk Range	0.10 - 1.06
Market Cap	-
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	-
Days to Cover	1

About NeuroSense Therapeutics Ltd

Sector

Health Care

Industry

Biotechnology

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and dev...

Got Questions? Ask

Analyze NRSNW's market performance

How is NRSNW's EBITDA trending?

What is NRSNW's average daily volume?

What is NRSNW's current market cap?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy NeuroSense Therapeutics (NRSNW) stock?

You can purchase shares of NeuroSense Therapeutics (NASDAQ:NRSNW) through any online brokerage.

View our list of the best stock brokerages

Who are NeuroSense Therapeutics (NRSNW) competitors?

Other companies in NeuroSense Therapeutics’s space includes: BeiGene (NASDAQ:ONC), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).

What is the forecast, or price target, for NeuroSense Therapeutics (NRSNW) stock?

There is no analysis for NeuroSense Therapeutics to provide a consensus price target.

What is the current price for NeuroSense Therapeutics (NRSNW)?

The stock price for NeuroSense Therapeutics (NASDAQ: NRSNW) is $0.26 last updated April 17, 2025 at 12:47 PM EDT.

Does NeuroSense Therapeutics (NRSNW) pay a dividend?

There are no upcoming dividends for NeuroSense Therapeutics.

When is NeuroSense Therapeutics (NASDAQ:NRSNW) reporting earnings?

NeuroSense Therapeutics does not have any upcoming earnings scheduled.

Is NeuroSense Therapeutics (NRSNW) going to split?

There is no upcoming split for NeuroSense Therapeutics.

What sector and industry does NeuroSense Therapeutics (NRSNW) operate in?

NeuroSense Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.